ALPHADENT
ActiveSummary
ALPHADENT has been active since 1975 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €7.5m and a net result of €278,380. Equity is growing by about 2.6% per year across the filed financial years. Its solvency ranks better than 95% of 8,981 sector peers (NACE 46, financial year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| David Dibon |
|
| Joost Bakker |
|
| Daniel Isidoro do Nascimento |
|
| Eduard van Nieuwkerk |
|
Owners and capital
Owners
2 ownersChain of control
- Henry Schein INCUS
- ARSEUS LAB
- ALPHADENT
Highest known parent: Henry Schein INC (United States). The sources do not say who stands above it.
Owners 2
- ARSEUS LABparent99.98%
- Henry Schein INCUSconsolidating parentconsolidates
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.